uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Tasquinimod mechanism of action biomarkers: correlation with pfs and survival in men with metastatic castrate resistant prostate cancer treated in a randomized phase 2 trial
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Urology.
Show others and affiliations
2012 (English)In: Annals of Oncology, ISSN 0923-7534, E-ISSN 1569-8041, Vol. 23, no S9, 303-303 p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2012. Vol. 23, no S9, 303-303 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-185373ISI: 000309409001400OAI: oai:DiVA.org:uu-185373DiVA: diva2:571886
Conference
37th Congress of the European-Society-for-Medical-Oncology (ESMO), SEP 28-OCT 02, 2012, Vienna, AUSTRIA
Available from: 2012-11-26 Created: 2012-11-22 Last updated: 2017-12-07Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Haggman, Michael

Search in DiVA

By author/editor
Haggman, Michael
By organisation
Urology
In the same journal
Annals of Oncology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 557 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf